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Mutations in XRCC1 cause 
cerebellar ataxia and 
peripheral neuropathy
Letter
Mutations in genes involved in single-
strand break repair (SSBR) have been 
linked to hereditary cerebellar ataxias. 
Notably, Ataxia-oculomotor apraxia 1 
(AOA1 (MIM: 2 08 920)), Spinocere-
bellar ataxia with axonal neuropathy 
1 (SCAN1 (MIM: 6 07 250)) and Atax-
ia-oculomotor apraxia 4 (AOA4 (MIM: 
616267616267616267)) are associ-
ated with mutations in APTX (MIM: 
606350), TDP1 (MIM: 607198) and 
PNKP (MIM: 605610), respectively.1 
Recently, compound heterozygous 
mutations in XRCC1 were identified 
in one individual with ocular motor 
apraxia, cerebellar ataxia and axonal 
neuropathy.2 However, as this study 
only identified a single case, the causal 
role of XRCC1 in Autosomal Recessive 
Cerebellar Ataxia (ARCA) remained in 
question and required replication in 
additional cases. Here we recapitulate 
and broaden this phenotype in two 
patients of Pakistani decent who were 
not known to be related. This confirms 
the role of XRCC1 in cerebellar ataxia. 
CLiniCaL features
Patient 1 was the eldest of three healthy 
siblings from a consanguineous relation-
ship (first cousins) (figure 1A). He walked 
independently at 15 months. Aged 3 
years, he had a persistent ataxic gait and 
recurrent falls. He experienced impaired 
fine motor skills and upper limb ataxia. 
In school, he had mild learning disabil-
ities, dysarthria and difficulties playing 
sports with painful cramps particularly 
after prolonged exertion. His examina-
tion was notable for prominent bilateral 
calf wasting and pes planus with impaired 
coordination and dysdiadochokinesis. 
Aged 15 years, he underwent an MRI 
brain, which was unremarkable. Nerve 
conduction studies and electromyo-
gram (EMG) showed a length-dependent 
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figure 1 (A) Pedigree of the family of patient 1. Open symbols represent unaffected individuals and filled symbols represent the affected individual. the 
proband is indicated by an arrow. Sanger sequencing chromatograms surround the symbols and show segregation of mutations. Blue boxes encompass the 
sites of interest. (B) Structural conservation of the mutated amino acid residue in XrCC1 across six species. Conservation among species of the amino acid 
residues was determined using Clustal W2 Software for multiple sequence alignment and plotted with BOXSHADe. (C) Pedigree of the family of patient 2. 
Open symbols represent unaffected individuals and filled symbols represent the affected individual. the proband is indicated by an arrow. Sanger sequencing 
chromatograms surround the symbols and show segregation of mutations. Blue boxes encompass the sites of interest. (D) Patient 1 : MrI examination 
of the brain demonstrating preservation of the supratentorial and upper cervical spinal cord neuroparenchymal volumes but disproportionate volume 
loss of the cerebellum and pons on the on the coronal FLAIr (i) and sagittal t1-weighted (ii) sequences. the axial t2-weighted sequences demonstrate 
associated volume loss of the middle (iii) and superior (iv) cerebellar peduncles (e) MrI examination of the brain and upper spinal cord. the coronal FLAIr 
(i) and sagittal t1-weighted (ii) sequences demonstrate mild cortical and subcortical supratentorial and upper spinal cord neuroparenchymal volume 
loss but disproportionate volume loss of the cerebellum. there is also subtle mild asymmetrical volume loss of the head of the right hippocampus. the 
axial t2-weighted sequences demonstrate associated volume loss of the middle (iii) and superior (iv) cerebellar peduncles. Sagittal t2-weighted (v) and 
axial  Multiple echo recombined Gradient echo  (MerGe) (vi) sequences demonstrate diminution of cervical spinal cord volume for age, particularly evident 
in the axial anterior–posterior dimension. FLAIr, fluid-attenuated inversion recovery.
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moderately severe sensorimotor neurop-
athy of axonal type (online supplementary 
table 1).
Currently, aged 22, he continues to 
ambulate independently however is prone 
to frequent falls. Eye examination shows 
slow saccadic initiation, hypometria, 
jerky pursuit and horizontal nystagmus 
on extreme gaze. He has a broad based 
gait, dysmetria and dysdiadochokinesis. 
Reflexes are absent in the lower limbs 
and planters are extensor on the left and 
equivocal on the right. Sensation to light 
touch and pain is normal with impaired 
vibration sense and proprioception. His 
recent MRI revealed cerebellar atrophy 
(figure 1D).
Patient 2 was also born to consanguin-
eous parents (figure 1C). He had recur-
rent falls and excessive clumsiness as an 
infant. Throughout his childhood, he 
experienced muscle cramps and stiffness 
in his lower limbs. He was dysarthric and 
had mild learning difficulties. Diffuse 
myotonia, predominantly in his hands, 
led to a diagnosis of myotonia congenita 
which was confirmed by the identification 
of a homozygous deletion of exons 17–22 
of the CLCN1 (MIM: 118425) gene.
Now aged 30, he walks without assis-
tance however requires rest after short 
distances. He has an ataxic waddling 
gait with diffuse muscle hypertrophy, 
particularly in the calves and bilateral 
pes cavus. He has moderate hand and 
eyelid myotonia. Examination of his eye 
movements reveal jerky pursuit with 
nystagmus on lateral gaze. He is areflexic 
throughout with flexor plantar responses 
and impaired sensation in the lower limbs 
below the knee. In addition to his neuro-
logical symptoms, he is infertile due to 
hypogonadism and azoospermia. EMG 
and MRI revealed a sensorimotor axonal 
neuropathy (online supplementary table 
1) and cerebellar atrophy (figure 1E).
WhoLe exome sequenCing
The patients and their unaffected parents 
were recruited with informed consent. 
DNA was extracted from peripheral blood 
and whole exome sequencing was carried 
out on the affected individuals and their 
parents. Homozygosity mapping was 
performed identifying three regions of 
homozygosity shared between the affected 
individuals including chromosome 1 (236 
645 670–237024414), chromosome 8 (90 
995 019–95 182 986) and chromosome 19 
(42 595 163–45 989 473). Variants within 
these regions were filtered for rare, homo-
zygous, mutations that were described as 
deleterious by in silico protein prediction 
programmes. This identified a homozy-
gous mutation, c.G1293C (p.K431N), in 
exon 11 of XRCC1 (NM_006297) in the 
affected individuals. This mutation lies 
within a shared haplotype on chromo-
some 19 and was predicted as deleterious 
by Sorting Intolerant From Tolerant (SIFT) 
and possibly damaging by polyphen. The 
missense mutation c.G1293C (p.K431N) 
forms part of the donor site of intron 11. 
Whole exome sequencing was used to estab-
lish intrafamilial segregation and confirmed 
with Sanger sequencing.
Comment
XRCC1 is a scaffold protein that enables 
SSBR through interactions with a number 
of single-strand repair enzymes. Struc-
turally, it comprises three globular 
domains, an N-terminal and a C-ter-
minal BRCT domain which interact 
with DNA polymerase and DNA ligase 
3α, respectively.3 The variant c.G1293C 
(p.K431N) is within the highly conserved 
central domain (BRCTa) which facilitates 
the binding of XRCC1 to ribosylated 
poly-ADP-ribose polymerase 1 (PARP1) 
activating partner proteins at sites of 
single-strand breaks. A loss of functional 
XRCC1 results in hyperactivation of 
PARP.2 This likely impedes the access of 
DNA repair proteins to the break, leading 
to defective repair and loss of cerebellar 
neurons. A mouse model with a condi-
tional XRCC1 deletion illustrated the crit-
ical physiological role of XRCC1 in the 
development of cerebellar interneurons.4
The variant, c.G1293C, exists in the 
heterozygote state in four individuals 
of South Asian decent with an allele 
frequency of 0.0002449 in ExAC. Our 
patients presented with a slowly progres-
sive cerebellar ataxia and sensorimotor 
axonal neuropathy, in concordance with 
the previously described case.2 Notably, 
our patients had a younger age of onset 
with observable signs at 3 years. Also, 
their examination elicited comparably 
subtle ocular signs with slightly prolonged 
latency in saccadic initiation in only one 
case.
XRCC1 is highly expressed in brain 
particularly in the cerebellum on the GTEX 
portal, however it is most highly expressed 
in the pituitary and gonads. This is inter-
esting considering the finding of infertility 
in patient 2, as in vitro studies of mouse 
and human sertoli cells demonstrate the 
involvement of XRCC1 and PARP1 (MIM: 
173870) in DNA repair which is essential to 
the survival of these quiescent cells.5
In conclusion, homozygous mutations in 
XRCC1 result in a core phenotype of slowly 
progressive cerebellar ataxia accompanied 
by sensorimotor neuropathy. Expression 
analysis together with our findings suggest 
that male infertility may also be a feature 
of this condition. However, alternative 
causes have not been ruled out. Therefore, 
further genotype–phenotype correlation in 
a larger cohort is warranted. Finally, this 
variant likely exists at a higher frequency 
than previously described, particularly in 
the South Asian population, and should 
be considered in patients with cerebellar 
atrophy and peripheral neuropathy from 
these regions.
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